======= MTHFD2 ======= == Gene Information == * **Official Symbol**: MTHFD2 * **Official Name**: methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=10797|10797]] * **UniProt**: [[https://www.uniprot.org/uniprot/P13995|P13995]] * **Interactions**: [[https://thebiogrid.org/search.php?search=MTHFD2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20MTHFD2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/604887|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a nuclear-encoded mitochondrial bifunctional enzyme with methylenetetrahydrofolate dehydrogenase and methenyltetrahydrofolate cyclohydrolase activities. The enzyme functions as a homodimer and is unique in its absolute requirement for magnesium and inorganic phosphate. Formation of the enzyme-magnesium complex allows binding of NAD. Alternative splicing results in two different transcripts, one protein-coding and the other not protein-coding. This gene has a pseudogene on chromosome 7. [provided by RefSeq, Mar 2009]. * **UniProt Summary**: Although its dehydrogenase activity is NAD-specific, it can also utilize NADP at a reduced efficiency. {ECO:0000269|PubMed:16100107}. |THF DHG CYH C| |THF DHG CYH| |methenyltetrahydrofolate cyclohydrolase activity| |methylenetetrahydrofolate dehydrogenase (NAD+) activity| |methylenetetrahydrofolate dehydrogenase (NADP+) activity| |tetrahydrofolate interconversion| |phosphate ion binding| |tetrahydrofolate metabolic process| |folic acid metabolic process| |one-carbon metabolic process| |folic acid-containing compound metabolic process| |pteridine-containing compound metabolic process| |water-soluble vitamin metabolic process| |dicarboxylic acid metabolic process| |vitamin metabolic process| |cellular modified amino acid metabolic process| |magnesium ion binding| |coenzyme metabolic process| |mitochondrial matrix| |cofactor metabolic process| |drug metabolic process| |cellular amide metabolic process| |carboxylic acid metabolic process| |oxidation-reduction process| |oxoacid metabolic process| |organic acid metabolic process| |mitochondrion| |extracellular space| |small molecule metabolic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp501|Methotrexate 0.01μM R08 exp501]]|-2.77| |[[:results:exp75|MK-1775 0.32μM R02 exp75]]|-2.45| |[[:results:exp372|Ibrutinib 1μM R07 exp372]]|-1.71| |[[:results:exp535|Trimetrexate 0.03μM R08 exp535]]|1.7| |[[:results:exp359|FK-506 30μM R07 exp359]]|1.71| |[[:results:exp90|WYE-354 6μM R02 exp90]]|1.71| |[[:results:exp183|IU1-C 25μM R04 exp183]]|1.77| |[[:results:exp290|LLY-283 2.6μM R06 exp290]]|1.81| |[[:results:exp13|Chloramphenicol 20μM R00 exp13]]|1.83| |[[:results:exp6|Bortezomib 0.005μM R00 exp6]]|1.85| |[[:results:exp212|Phenformin 20μM R05 exp212]]|1.88| |[[:results:exp504|MK2206 4μM R08 exp504]]|1.9| |[[:results:exp447|Amiloride 100μM R08 exp447]]|1.92| |[[:results:exp490|Hydroxychloroquine 30μM R08 exp490]]|1.94| |[[:results:exp497|Lead acetate 2000μM R08 exp497]]|1.94| |[[:results:exp288|HMS-I2 10μM R06 exp288]]|1.95| |[[:results:exp283|Glyphosate 1000μM R06 exp283]]|1.99| |[[:results:exp214|2-Deoxy-D-glucose 800μM R05 exp214]]|2.02| |[[:results:exp515|PU-H71 1μM R08 exp515]]|2.07| |[[:results:exp502|Milciclib 2μM R08 exp502]]|2.3| |[[:results:exp81|Selumetinib 20μM R02 exp81]]|2.32| |[[:results:exp263|Aphidicolin 0.04μM R06 exp263]]|2.34| |[[:results:exp248|UM0131023 0.05μM R05 exp248]]|2.34| |[[:results:exp282|Fluvastatin 2.2μM R06 exp282]]|2.58| |[[:results:exp439|QNZ 0.01μM R08 exp439]]|2.62| |[[:results:exp191|Hypoxia 5%O2 R04 exp191]]|2.77| |[[:results:exp274|Citral 50μM R06 exp274]]|2.97| |[[:results:exp116|AICAR 240μM R03 exp116]]|5.41| |[[:results:exp211|AICAR 240μM R05 exp211]]|5.45| ^Gene^Correlation^ |[[:human genes:m:mthfd1l|MTHFD1L]]|0.661| |[[:human genes:s:slc25a32|SLC25A32]]|0.658| |[[:human genes:m:mtrr|MTRR]]|0.579| |[[:human genes:s:shmt2|SHMT2]]|0.572| |[[:human genes:m:mtr|MTR]]|0.518| |[[:human genes:m:mmachc|MMACHC]]|0.455| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 4149 * **Expression level (log2 read counts)**: 8.21 {{:chemogenomics:nalm6 dist.png?nolink |}}